Cancer52 – 55% of UK cancer deaths are from rare and less common cancers.
Despite this, these cancers remain severely under represented and under-funded across all areas, including policy, services and research.
Cancer52 is an alliance of over 100 organisations working to address this inequality and improve outcomes for patients with these highly challenging diseases.